214 related articles for article (PubMed ID: 19863058)
1. Sphingomyelinase-induced phase transformations: causing morphology switches and multiple-time-domain ceramide generation in model raft membranes.
Chao L; Gast AP; Hatton TA; Jensen KF
Langmuir; 2010 Jan; 26(1):344-56. PubMed ID: 19863058
[TBL] [Abstract][Full Text] [Related]
2. Two-dimensional solvent-mediated phase transformation in lipid membranes induced by sphingomyelinase.
Chao L; Chen F; Jensen KF; Hatton TA
Langmuir; 2011 Aug; 27(16):10050-60. PubMed ID: 21675765
[TBL] [Abstract][Full Text] [Related]
3. Shape transitions and lattice structuring of ceramide-enriched domains generated by sphingomyelinase in lipid monolayers.
Härtel S; Fanani ML; Maggio B
Biophys J; 2005 Jan; 88(1):287-304. PubMed ID: 15489298
[TBL] [Abstract][Full Text] [Related]
4. Lipid raft composition modulates sphingomyelinase activity and ceramide-induced membrane physical alterations.
Silva LC; Futerman AH; Prieto M
Biophys J; 2009 Apr; 96(8):3210-22. PubMed ID: 19383465
[TBL] [Abstract][Full Text] [Related]
5. Rapid phase change of lipid microdomains in giant vesicles induced by conversion of sphingomyelin to ceramide.
Taniguchi Y; Ohba T; Miyata H; Ohki K
Biochim Biophys Acta; 2006 Feb; 1758(2):145-53. PubMed ID: 16580624
[TBL] [Abstract][Full Text] [Related]
6. Formation of ceramide-enriched domains in lipid particles enhances the binding of apolipoprotein E.
Morita SY; Nakano M; Sakurai A; Deharu Y; Vertut-Doï A; Handa T
FEBS Lett; 2005 Mar; 579(7):1759-64. PubMed ID: 15757672
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelinase induces lipid microdomain formation in a fluid phosphatidylcholine/sphingomyelin membrane.
Holopainen JM; Subramanian M; Kinnunen PK
Biochemistry; 1998 Dec; 37(50):17562-70. PubMed ID: 9860872
[TBL] [Abstract][Full Text] [Related]
8. Hemolysis induced by Bacillus cereus sphingomyelinase.
Oda M; Takahashi M; Matsuno T; Uoo K; Nagahama M; Sakurai J
Biochim Biophys Acta; 2010 Jun; 1798(6):1073-80. PubMed ID: 20214877
[TBL] [Abstract][Full Text] [Related]
9. Detergent-resistant, ceramide-enriched domains in sphingomyelin/ceramide bilayers.
Sot J; Bagatolli LA; Goñi FM; Alonso A
Biophys J; 2006 Feb; 90(3):903-14. PubMed ID: 16284266
[TBL] [Abstract][Full Text] [Related]
10. Tunable nucleation time of functional sphingomyelinase--lipid features studied by membrane array statistic tool.
Lin CY; Chao L
Langmuir; 2013 Oct; 29(42):13008-17. PubMed ID: 24059643
[TBL] [Abstract][Full Text] [Related]
11. Bidirectional control of sphingomyelinase activity and surface topography in lipid monolayers.
Fanani ML; Härtel S; Oliveira RG; Maggio B
Biophys J; 2002 Dec; 83(6):3416-24. PubMed ID: 12496108
[TBL] [Abstract][Full Text] [Related]
12. Differential regulation of ceramide in lipid-rich microdomains (rafts): antagonistic role of palmitoyl:protein thioesterase and neutral sphingomyelinase 2.
Goswami R; Ahmed M; Kilkus J; Han T; Dawson SA; Dawson G
J Neurosci Res; 2005 Jul; 81(2):208-17. PubMed ID: 15929065
[TBL] [Abstract][Full Text] [Related]
13. Surface tension induced by sphingomyelin to ceramide conversion in lipid membranes.
López-Montero I; Vélez M; Devaux PF
Biochim Biophys Acta; 2007 Mar; 1768(3):553-61. PubMed ID: 17292325
[TBL] [Abstract][Full Text] [Related]
14. Cholesterol modulation of sphingomyelinase activity at physiological temperatures.
Contreras FX; Sot J; Ruiz-Argüello MB; Alonso A; Goñi FM
Chem Phys Lipids; 2004 Jul; 130(2):127-34. PubMed ID: 15172829
[TBL] [Abstract][Full Text] [Related]
15. Full CD3/TCR activation through cholesterol-depleted lipid rafts.
Rouquette-Jazdanian AK; Pelassy C; Breittmayer JP; Aussel C
Cell Signal; 2007 Jul; 19(7):1404-18. PubMed ID: 17303381
[TBL] [Abstract][Full Text] [Related]
16. Ceramide promotes restructuring of model raft membranes.
Johnston I; Johnston LJ
Langmuir; 2006 Dec; 22(26):11284-9. PubMed ID: 17154617
[TBL] [Abstract][Full Text] [Related]
17. Sphingomyelinase-induced domain shape relaxation driven by out-of-equilibrium changes of composition.
Fanani ML; De Tullio L; Hartel S; Jara J; Maggio B
Biophys J; 2009 Jan; 96(1):67-76. PubMed ID: 18849413
[TBL] [Abstract][Full Text] [Related]
18. Sphingomyelinase acts by an area-activated mechanism on the liquid-expanded phase of sphingomyelin monolayers.
De Tullio L; Maggio B; Fanani ML
J Lipid Res; 2008 Nov; 49(11):2347-55. PubMed ID: 18509194
[TBL] [Abstract][Full Text] [Related]
19. Ordered-disordered domain coexistence in ternary lipid monolayers activates sphingomyelinase by clearing ceramide from the active phase.
Ale EC; Maggio B; Fanani ML
Biochim Biophys Acta; 2012 Nov; 1818(11):2767-76. PubMed ID: 22763279
[TBL] [Abstract][Full Text] [Related]
20. Sphingomyelinase and membrane sphingomyelin content: determinants ofProximal tubule cell susceptibility to injury.
Zager RA; Burkhart KM; Johnson A
J Am Soc Nephrol; 2000 May; 11(5):894-902. PubMed ID: 10770967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
